Therapy Areas: Cardiovascular
Zelira Therapeutics concludes world's first clinical trial in insomnia patients with medical cannabis ZTL-101
8 April 2020 - Cannabis medicines company Zelira Therapeutics Ltd (ASX:ZLD) (OTCQB:ZLDAF) said on Tuesday that its ZTL-101 medicinal cannabis trial for insomnia demonstrated the treatment as safe and ...
Eurofins reports availability of COVID-19 antibody testing by Boston Heart Diagnostics
6 April 2020 - The Eurofins' U.S. Clinical Diagnostics network announced on Friday that its subsidiary Boston Heart Diagnostics, a cardiovascular testing company, will commence blood-based antibo...
FARXIGA Phase III DAPA-CKD Trial Will Be Stopped Early After Overwhelming Efficacy in Patients with Chronic Kidney Disease
2 April 2020 - - The Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) Phase III trial for FARXIGA (dapagliflozin) in p...
Amgen to launch full global pipeline in Japan with formation of Japanese wholly owned affiliate
1 April 2020 - Biotechnology company Amgen (NASDAQ:AMGN) revealed on Tuesday the completion of the acquisition of the acquisition of 49% of shares of Amgen Astellas BioPharma KK (AABP) from Astellas.A...
AstraZeneca's Lokelma approved in Japan for treatment of hyperkalaemia
27 March 2020 - Biopharmaceutical company AstraZeneca Plc (STO:AZN) (LON:AZN) reported on Thursday the approval of Lokelma (sodium zirconium cyclosilicate) in Japan for the treatment of patients with ...
Cardax Releases White Paper on the Potential Role of Astaxanthin in the Treatment of Coronavirus Disease
24 March 2020 - - US-based biopharmaceutical company Cardax, Inc. (OTCQB: CDXI) has released a white paper outlining the potential role of astaxanthin in the treatment of coronavirus disease and is se...